Risk factors for local recurrence after breast-conserving surgery

British Journal of Surgery

Volumn 90, Issue 9, 2003, Pages 1093-1102

  Fredriksson, I ^a   Liljegren, G ^b   Palm Sjovall M ^c   Arnesson, L G ^d   Emdin, S O ^e   Fornander, T ^f   Lindgren, A ^g   Nordgren, H ^h   Idvall, I ⁱ   Holmqvist, M ^h   Holmberg, L ^h   Frisell, J ^f  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g FALUN HOSPITAL   (Sweden)

^h UPPSALA UNIVERSITY HOSPITAL   (Sweden)

ⁱ HELSINGBORG HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; HORMONE; METHOTREXATE; TAMOXIFEN;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CARCINOMA IN SITU; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTECTION; RISK FACTOR; SCORING SYSTEM; TUMOR LOCALIZATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; TREATMENT OUTCOME;

EID: 0141518226     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4206     Document Type: Article

References (39)

1. Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1988; 14: 3-10.
2. Fowble BL, Schultz DJ, Overmoyer B, Solin LJ, Fox K, Jardines L et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 1994; 30: 23-33.
3. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H. Risk factors in breast-conservation therapy. J Clin Oncol 1994; 12: 653-660.
4. Elkhuizen PH, van de Vijver MJ, Hermans J, Zonderland HM, van de Velde CJ, Leer JW. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998; 40: 859-867.
5. Cowen D, Jacquemier J, Houvenaeghel G, Viens P, Puig B, Bardou VJ et al. Local and distant recurrence after conservative management of 'very low-risk' breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys 1998; 41: 801-807.
6. Voogd AC, Nielsen M, Peterse JL, Blichert-Toft M, Bartelink H, Overgaard M et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001; 19: 1688-1697.
7. Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994; 74: 1746-1751.
8. Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996; 78: 1921-1928.
9. DiBiase SJ, Komarnicky LT, Schwartz GF, Xie Y, Mansfield CM. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 1998; 82: 2212-2220.
10. Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999; 44: 1005-1015.
11. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000; 18: 1668-1675.
12. Leopold KA, Recht A, Schnitt SJ, Connolly JL, Rose MA, Silver B et al. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys 1989; 16: 11-16.
13. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D et al. Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 1990; 212: 38-44.
14. Fourquet A, Campana F, Zafrani B, Mosseri V, Vielh P, Durand JC et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989; 17: 719-725.
15. Locker AP, Ellis IO, Morgan DA, Elston CW, Mitchell A, Blamey RW. Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989; 76: 890-894.
16. Sinn HP, Anton HW, Magener A, von Fournier D, Bastert G, Otto HF. Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy. Eur J Cancer 1998; 34: 646-653.
17. Boyages J, Recht A, Connolly JL, Schnitt SJ, Gelman R, Kooy H et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 1990; 19: 29-41.
18. Jacquemier J, Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer 1990; 61: 873-876.
19. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D et al. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 1990; 65: 1867-1878.
20. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
21. Nixon AJ, Schnitt SJ, Gelman R, Gage I, Bornstein B, Hetelekidis S et al. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer 1996; 78: 1426-1431.
22. Galea MH, Blamey RW, Elston CE, Ellis IO. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207-219.
23. Aspegren K, Holmberg L, Adami HO. Standardization of the surgical technique in breast-conserving treatment of mammary cancer. Br J Surg 1988; 75: 807-810.
24. Fredriksson I, Liljegren G, Arnesson LG, Emdin SO, Palm-Sjovall M, Fornander T et al. Time trends in the results of breast conservation in 4694 women. Eur J Cancer 2001; 37: 1537-1544.
25. Fredriksson I, Liljegren G, Arnesson LG, Emdin SO, Palm-Sjovall M, Fornander T et al. Consequences of axillary recurrence after conservative breast surgery. Br J Surg 2002; 89: 902-908.
26. Nystrom L, Larsson LG, Rutqvist LE, Lindgren A, Lindqvist M, Ryden S et al. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995; 34: 145-152.
27. Symmers WSC, Elston CW, Ellis IO. Systemic Pathology. Churchill Livingstone: Edinburgh, 1998.
28. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345: 1154-1157.
29. Swedish Breast Cancer Cooperative Group. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. J Natl Cancer Inst 1996; 88: 1543-1549.
30. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993; 328: 1587-1591.
31. Whelan T, Clark R, Roberts R, Levine M, Foster G. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys 1994; 30: 11-16.
32. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996; 88: 1659-1664.
33. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333: 1456-1461.
34. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996; 348: 708-713.
35. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999; 17: 2326-2333.
36. Dalberg K, Johansson H, Johansson U, Rutqvist LE. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Stockholm Breast Cancer Study Group. Cancer 1998; 82: 2204-2211.
37. Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12: 888-894.
38. Liljegren G, Lindgren A, Bergh J, Nordgren H, Tabar L, Holmberg L. Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncol 1997; 8: 235-241.
39. Fisher B, Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg 1994; 18: 63-69.